<tr id='r2mcq'><strong id='r2mcq'></strong><small id='r2mcq'></small><button id='r2mcq'></button><li id='r2mcq'><noscript id='r2mcq'><big id='r2mcq'></big><dt id='r2mcq'></dt></noscript></li></tr><ol id='r2mcq'><option id='r2mcq'><table id='r2mcq'><blockquote id='r2mcq'><tbody id='r2mcq'></tbody></blockquote></table></option></ol><u id='r2mcq'></u><kbd id='r2mcq'><kbd id='r2mcq'></kbd></kbd>
Solventum宣布，醫學博士Ryan Egeland被任命為首席醫療官。Ryan Egeland從Crossfire Medical加入Solventum，自2022年起擔任首席執行官。此前，他擔任Cardiovascular Systems, Inc. (CSI)的戰略風險投資主管和首席醫療官。在CSI任職之前，他領導了Medtronic, Covidien和ev3的業務開發和許可，醫療和科學事務以及產品營銷團隊。(美通社)
<tr id='Zz4XE'><strong id='mXu1d'></strong><small id='F7QtR'></small><button id='WeChH'></button><li id='yVcaM'><noscript id='OsPAC'><big id='Sc2IG'></big><dt id='v4I34'></dt></noscript></li></tr><ol id='BnDng'><option id='0TuFE'><table id='43Vsf'><blockquote id='ew4l1'><tbody id='4i4xu'></tbody></blockquote></table></option></ol><u id='CehWv'></u><kbd id='4GKof'><kbd id='krY5M'></kbd></kbd>
